{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T02:28:38Z","timestamp":1794623318301,"version":"4.9.1"},"reference-count":50,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold> Bipolar disorder (BD) is a leading cause of disability. Systematic reviews of randomized trials for the treatment of the maintenance phase of BD are lacking.<\/jats:p><jats:p><jats:bold>Objectives:\u2002<\/jats:bold> To determine the efficacy and tolerability of mood stabilizers and antipsychotics in the maintenance treatment of BD.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> We systematically reviewed randomized controlled trials of licensed medications for the treatment of any phase of BD. We included randomized controlled trials comparing a medication to placebo or another medication. Comprehensive searches of electronic databases were conducted to March 2005. Outcomes investigated were relapse due to mania, depression or any mood episode, and withdrawal due to any reason or due to an adverse event. Data were combined through meta\u2010analysis.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Fourteen studies (<jats:italic>n<\/jats:italic>\u2003=\u20032,526) met the inclusion criteria. Lithium, lamotrigine, olanzapine and valproate semisodium each demonstrated evidence to support long\u2010term use. Compared with placebo, all medications were more effective at preventing relapse because of any mood episode. Hazard ratios (HR) were 0.68 [95% confidence interval (CI)\u2003=\u20030.53\u20130.86] for lithium, 0.68 (95% CI\u2003=\u20030.55\u20130.85) for lamotrigine, and 0.82 (95% CI\u2003=\u20030.57\u20131.20) for valproate semisodium; for olanzapine, the risk ratio (RR) was 0.58 (95% CI\u2003= 0.49\u20130.69). Lithium and olanzapine significantly reduced manic relapses (HR\u2003=\u20030.53; 95% CI\u2003=\u20030.35\u20130.79 and RR\u2003=\u20030.37; 95% CI\u2003=\u20030.24\u20130.57, respectively). Lamotrigine and valproate semisodium significantly reduced depressive relapses (HR\u2003=\u20030.65; 95% CI\u2003=\u20030.46\u20130.91 and RR\u2003=\u20030.40; 95% CI\u2003=\u20030.20\u20130.82, respectively). Lithium significantly reduced manic relapses compared with lamotrigine (HR\u2003=\u20030.56; 95% CI\u2003=\u20030.34\u20130.92) and olanzapine significantly reduced manic relapses compared with lithium (RR\u2003=\u20031.69; 95% CI\u2003=\u20031.12\u20132.55). Withdrawal due to an adverse event was approximately twice as likely with lithium compared with valproate semisodium (RR\u2003=\u20031.81; 95% CI\u2003=\u20031.08\u20133.03) and lamotrigine (RR\u2003=\u20032.20; 95% CI\u2003=\u20031.31\u20133.70). There were few data for carbamazepine or medications given as adjunct therapy.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Mood stabilizers have differing profiles of efficacy and tolerability, suggesting complementary roles in long\u2010term maintenance treatment.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2007.00490.x","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T04:38:10Z","timestamp":1180759090000},"page":"394-412","source":"Crossref","is-referenced-by-count":152,"title":["Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials"],"prefix":"10.1111","volume":"9","author":[{"given":"Lesley A","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00377-9"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07492-2"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.171.2.113"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.171.2.120"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.392"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n1106"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0906"},{"key":"e_1_2_7_9_2","volume-title":"Valproic Acid, Valproate and Divalproex in the Maintenance Treatment of Bipolar Disorder (Cochrane Review). The Cochrane Library, Issue 1","author":"Macritchie K","year":"2004"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.2.217"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470693926.ch5"},{"key":"e_1_2_7_13_2","first-page":"87","volume-title":"Systematic Reviews in Health Care","author":"Deeks JJ","year":"2001"},{"key":"e_1_2_7_14_2","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions, Vol. 4.2.4. Updated March 2005","author":"The Cochrane Collaboration","year":"2005"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_7_16_2","volume-title":"Cost\u2010effectiveness Evaluation of Divalproex Sodium Versus Lithium in the Treatment of Bipolar Disorder. One Hundred and Fifty\u2010Second Annual Meeting of the American Psychiatric Association","author":"Hirschfeld RMA","year":"1999"},{"key":"e_1_2_7_17_2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S092427080003564X","article-title":"Acute and continuation pharmacological treatment of children and adolescents with bipolar disorders; a summary of two previous studies","volume":"12","author":"Kowatch RA","year":"2000","journal-title":"Acta Neuropsychiatr"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.153.2.198"},{"key":"e_1_2_7_19_2","first-page":"490","article-title":"The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double\u2010blind 3\u2010year trial in 83 patients","volume":"47","author":"Placidi GF","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200323100-00006"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1263"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0206"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n1102"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.148.6.723"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00007"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199914050-00003"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300190"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200006000-00009"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000054844"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.150.2.180"},{"key":"e_1_2_7_31_2","volume-title":"Carbamazepine Versus Lithium in the Prophylaxis of Bipolar Affective Disorders. A Randomised, Double\u2010blind 1\u2010year Study in 168 Patients. Tenth European College of Neuropsychopharmacology Congress, Vienna, Austria, 13\u201317 September 1997","author":"Wolf C","year":"1997"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780330060006"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.5.481"},{"key":"e_1_2_7_34_2","first-page":"2152","volume-title":"A double\u2010blind 20\u2010month, maintenance study of lithium versus divalproex in rapid\u2010cycling bipolar disorder. Am J Psychiatry","author":"Calabrese JR","year":"2005"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1992.tb01453.x"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(96)01427-9"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1982.04290090053011"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00431111"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.01750330035006"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v58n0301"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.163.2.247"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.4.337"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.7.1281"},{"issue":"10","key":"e_1_2_7_44_2","first-page":"16","article-title":"Strategies for preventing the recurrence of bipolar disorder","volume":"65","author":"Ghaemi SN","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363190-00009"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.6.530"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1991.01810250064008"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2004.09.009"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.178.41.s191"},{"key":"e_1_2_7_51_2","volume-title":"Randomised Clinical Trials of Treatments for Bipolar Disorder","author":"BALANCE and BALANCE\u00a02"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2007.00490.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2007.00490.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T21:42:37Z","timestamp":1696887757000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2007.00490.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1111\/j.1399-5618.2007.00490.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2007.00490.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}